

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-myosin filament sliding (GO:0033275) | 5.74570922 |
| 2 | muscle filament sliding (GO:0030049) | 5.74570922 |
| 3 | actin-mediated cell contraction (GO:0070252) | 4.74206251 |
| 4 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.67803680 |
| 5 | skeletal muscle contraction (GO:0003009) | 4.41222783 |
| 6 | histone H3-K9 demethylation (GO:0033169) | 4.26735249 |
| 7 | regulation of NFAT protein import into nucleus (GO:0051532) | 4.20330014 |
| 8 | sarcomere organization (GO:0045214) | 4.19465638 |
| 9 | mitotic chromosome condensation (GO:0007076) | 4.14033460 |
| 10 | striated muscle contraction (GO:0006941) | 4.01298190 |
| 11 | 4-hydroxyproline metabolic process (GO:0019471) | 3.90191096 |
| 12 | gluconeogenesis (GO:0006094) | 3.87528617 |
| 13 | glycolytic process (GO:0006096) | 3.85688867 |
| 14 | NADH metabolic process (GO:0006734) | 3.84352559 |
| 15 | myofibril assembly (GO:0030239) | 3.76989635 |
| 16 | actin filament-based movement (GO:0030048) | 3.74737888 |
| 17 | cardiac muscle contraction (GO:0060048) | 3.69539326 |
| 18 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.52838952 |
| 19 | hexose biosynthetic process (GO:0019319) | 3.52731939 |
| 20 | cardiac myofibril assembly (GO:0055003) | 3.51852536 |
| 21 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.48823752 |
| 22 | peptidyl-lysine dimethylation (GO:0018027) | 3.38117044 |
| 23 | mitochondrial fusion (GO:0008053) | 3.30769580 |
| 24 | L-phenylalanine catabolic process (GO:0006559) | 3.25871546 |
| 25 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.25871546 |
| 26 | COPII vesicle coating (GO:0048208) | 3.21544500 |
| 27 | actomyosin structure organization (GO:0031032) | 3.20188682 |
| 28 | monosaccharide biosynthetic process (GO:0046364) | 3.19976420 |
| 29 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.19234340 |
| 30 | L-phenylalanine metabolic process (GO:0006558) | 3.15827586 |
| 31 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.15827586 |
| 32 | regulation of relaxation of muscle (GO:1901077) | 3.15814406 |
| 33 | intestinal cholesterol absorption (GO:0030299) | 3.13476625 |
| 34 | valine metabolic process (GO:0006573) | 3.12185396 |
| 35 | glycogen biosynthetic process (GO:0005978) | 3.10668632 |
| 36 | glucan biosynthetic process (GO:0009250) | 3.10668632 |
| 37 | cardiac muscle hypertrophy (GO:0003300) | 3.09078672 |
| 38 | cysteine metabolic process (GO:0006534) | 3.08965080 |
| 39 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.04570428 |
| 40 | muscle cell cellular homeostasis (GO:0046716) | 3.03095921 |
| 41 | glycogen catabolic process (GO:0005980) | 3.00424554 |
| 42 | fructose metabolic process (GO:0006000) | 2.99699267 |
| 43 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.99346375 |
| 44 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.98890568 |
| 45 | striated muscle hypertrophy (GO:0014897) | 2.96967953 |
| 46 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.95597391 |
| 47 | adherens junction assembly (GO:0034333) | 2.92813649 |
| 48 | COPI coating of Golgi vesicle (GO:0048205) | 2.92225358 |
| 49 | Golgi transport vesicle coating (GO:0048200) | 2.92225358 |
| 50 | regulation of early endosome to late endosome transport (GO:2000641) | 2.91519138 |
| 51 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.88177390 |
| 52 | regulation of RNA export from nucleus (GO:0046831) | 2.87308706 |
| 53 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.87286267 |
| 54 | lysine catabolic process (GO:0006554) | 2.87237143 |
| 55 | lysine metabolic process (GO:0006553) | 2.87237143 |
| 56 | skeletal muscle fiber development (GO:0048741) | 2.85842481 |
| 57 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.85403585 |
| 58 | regulation of chromatin binding (GO:0035561) | 2.84440225 |
| 59 | focal adhesion assembly (GO:0048041) | 2.83121320 |
| 60 | cell-substrate adherens junction assembly (GO:0007045) | 2.83121320 |
| 61 | serine family amino acid catabolic process (GO:0009071) | 2.83030918 |
| 62 | histone lysine demethylation (GO:0070076) | 2.80330693 |
| 63 | regulation of actin filament-based movement (GO:1903115) | 2.77631124 |
| 64 | myoblast fusion (GO:0007520) | 2.77195900 |
| 65 | histone H3-K36 demethylation (GO:0070544) | 2.77057483 |
| 66 | synaptonemal complex assembly (GO:0007130) | 2.76256706 |
| 67 | histone demethylation (GO:0016577) | 2.75207365 |
| 68 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.73940056 |
| 69 | muscle hypertrophy in response to stress (GO:0003299) | 2.73940056 |
| 70 | cardiac muscle adaptation (GO:0014887) | 2.73940056 |
| 71 | glucan catabolic process (GO:0009251) | 2.72544600 |
| 72 | response to muscle activity (GO:0014850) | 2.71980940 |
| 73 | regulation of cholesterol homeostasis (GO:2000188) | 2.70555391 |
| 74 | glyoxylate metabolic process (GO:0046487) | 2.70261881 |
| 75 | muscle cell fate commitment (GO:0042693) | 2.69069654 |
| 76 | negative regulation of cell size (GO:0045792) | 2.68418797 |
| 77 | protein localization to microtubule (GO:0035372) | 2.68026944 |
| 78 | cellular protein complex localization (GO:0034629) | 2.67079826 |
| 79 | response to inactivity (GO:0014854) | 2.66877824 |
| 80 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.66746599 |
| 81 | nuclear pore complex assembly (GO:0051292) | 2.66426119 |
| 82 | aromatic amino acid family catabolic process (GO:0009074) | 2.65914584 |
| 83 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.65168875 |
| 84 | positive regulation of myotube differentiation (GO:0010831) | 2.64851731 |
| 85 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.63447952 |
| 86 | protein carboxylation (GO:0018214) | 2.63447952 |
| 87 | protein retention in ER lumen (GO:0006621) | 2.62806779 |
| 88 | muscle contraction (GO:0006936) | 2.62137414 |
| 89 | regulation of skeletal muscle contraction (GO:0014819) | 2.60257745 |
| 90 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.58973492 |
| 91 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.58653282 |
| 92 | pyruvate metabolic process (GO:0006090) | 2.58547643 |
| 93 | sodium ion export (GO:0071436) | 2.57853528 |
| 94 | urea metabolic process (GO:0019627) | 2.57717317 |
| 95 | urea cycle (GO:0000050) | 2.57717317 |
| 96 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.57669513 |
| 97 | fatty acid beta-oxidation (GO:0006635) | 2.56084412 |
| 98 | response to nitrosative stress (GO:0051409) | 2.55411925 |
| 99 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.54164331 |
| 100 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.53714844 |
| 101 | exocrine pancreas development (GO:0031017) | 2.53210961 |
| 102 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.53057117 |
| 103 | positive regulation of p38MAPK cascade (GO:1900745) | 2.52905764 |
| 104 | fatty acid oxidation (GO:0019395) | 2.52482065 |
| 105 | uronic acid metabolic process (GO:0006063) | 2.51313328 |
| 106 | glucuronate metabolic process (GO:0019585) | 2.51313328 |
| 107 | paraxial mesoderm development (GO:0048339) | 2.51292814 |
| 108 | myotube differentiation (GO:0014902) | 2.51257157 |
| 109 | tyrosine metabolic process (GO:0006570) | 2.51231395 |
| 110 | glycine metabolic process (GO:0006544) | 2.49737158 |
| 111 | sulfur amino acid catabolic process (GO:0000098) | 2.49508086 |
| 112 | tricarboxylic acid cycle (GO:0006099) | 2.48958254 |
| 113 | growth hormone receptor signaling pathway (GO:0060396) | 2.48926010 |
| 114 | positive regulation of nuclease activity (GO:0032075) | 2.48474228 |
| 115 | cellular glucuronidation (GO:0052695) | 2.48263905 |
| 116 | protein demethylation (GO:0006482) | 2.47488207 |
| 117 | protein dealkylation (GO:0008214) | 2.47488207 |
| 118 | striated muscle adaptation (GO:0014888) | 2.47246111 |
| 119 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.46798366 |
| 120 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.46767202 |
| 121 | muscle hypertrophy (GO:0014896) | 2.46665667 |
| 122 | regulation of the force of heart contraction (GO:0002026) | 2.46580301 |
| 123 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.46538594 |
| 124 | glycogen metabolic process (GO:0005977) | 2.46528198 |
| 125 | synaptonemal complex organization (GO:0070193) | 2.45875924 |
| 126 | RNA stabilization (GO:0043489) | 2.45869238 |
| 127 | mRNA stabilization (GO:0048255) | 2.45869238 |
| 128 | cellular polysaccharide catabolic process (GO:0044247) | 2.45306987 |
| 129 | ER-nucleus signaling pathway (GO:0006984) | 2.45078712 |
| 130 | lipid oxidation (GO:0034440) | 2.44539054 |
| 131 | negative regulation of fatty acid transport (GO:2000192) | 2.44522187 |
| 132 | muscle organ morphogenesis (GO:0048644) | 2.44027914 |
| 133 | radial glial cell differentiation (GO:0060019) | 2.43344185 |
| 134 | serine family amino acid metabolic process (GO:0009069) | 2.43029874 |
| 135 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.42471852 |
| 136 | positive regulation of histone deacetylation (GO:0031065) | 2.41501971 |
| 137 | cell communication by electrical coupling (GO:0010644) | 2.40719858 |
| 138 | negative regulation of skeletal muscle tissue development (GO:0048642) | 2.40645413 |
| 139 | amino-acid betaine metabolic process (GO:0006577) | 2.39787135 |
| 140 | carnitine shuttle (GO:0006853) | 2.39675900 |
| 141 | glucose metabolic process (GO:0006006) | 2.39601996 |
| 142 | cellular response to unfolded protein (GO:0034620) | 2.39485060 |
| 143 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.39005812 |
| 144 | regulation of cholesterol metabolic process (GO:0090181) | 2.37979006 |
| 145 | endocrine pancreas development (GO:0031018) | 2.37581729 |
| 146 | positive regulation of fatty acid oxidation (GO:0046321) | 2.34868768 |
| 147 | regulation of p38MAPK cascade (GO:1900744) | 2.32213151 |
| 148 | kynurenine metabolic process (GO:0070189) | 2.31799705 |
| 149 | intestinal absorption (GO:0050892) | 2.29037668 |
| 150 | hormone catabolic process (GO:0042447) | 2.28992606 |
| 151 | phospholipid homeostasis (GO:0055091) | 2.28358731 |
| 152 | tryptophan metabolic process (GO:0006568) | 2.28185655 |
| 153 | regulation of nuclease activity (GO:0032069) | 2.28115431 |
| 154 | nitrogen cycle metabolic process (GO:0071941) | 2.27540279 |
| 155 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.27457250 |
| 156 | low-density lipoprotein particle clearance (GO:0034383) | 2.26807101 |
| 157 | response to mercury ion (GO:0046689) | 2.26681870 |
| 158 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.23899347 |
| 159 | positive regulation of hormone metabolic process (GO:0032352) | 2.23618695 |
| 160 | drug transmembrane transport (GO:0006855) | 2.22752091 |
| 161 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.22447071 |
| 162 | creatine metabolic process (GO:0006600) | 2.22043167 |
| 163 | myelin maintenance (GO:0043217) | 2.21543797 |
| 164 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.21469231 |
| 165 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.21375210 |
| 166 | branched-chain amino acid metabolic process (GO:0009081) | 2.20633558 |
| 167 | regulation of fibrinolysis (GO:0051917) | 2.20502451 |
| 168 | fatty acid catabolic process (GO:0009062) | 2.19967217 |
| 169 | sequestering of metal ion (GO:0051238) | 2.18677915 |
| 170 | coronary vasculature morphogenesis (GO:0060977) | 2.18654796 |
| 171 | 2-oxoglutarate metabolic process (GO:0006103) | 2.17721111 |
| 172 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.17554847 |
| 173 | fatty acid transmembrane transport (GO:1902001) | 2.17229348 |
| 174 | cellular response to topologically incorrect protein (GO:0035967) | 2.16874689 |
| 175 | indolalkylamine catabolic process (GO:0046218) | 2.16839233 |
| 176 | tryptophan catabolic process (GO:0006569) | 2.16839233 |
| 177 | indole-containing compound catabolic process (GO:0042436) | 2.16839233 |
| 178 | positive regulation of protein kinase C signaling (GO:0090037) | 2.16794302 |
| 179 | hepatocyte apoptotic process (GO:0097284) | 2.16675079 |
| 180 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.16305650 |
| 181 | peptidyl-proline hydroxylation (GO:0019511) | 2.16215831 |
| 182 | protein hydroxylation (GO:0018126) | 2.15713507 |
| 183 | cellular modified amino acid catabolic process (GO:0042219) | 2.15614407 |
| 184 | negative regulation of fibrinolysis (GO:0051918) | 2.14936693 |
| 185 | glandular epithelial cell development (GO:0002068) | 2.14484831 |
| 186 | regulation of triglyceride catabolic process (GO:0010896) | 2.14325280 |
| 187 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.13416177 |
| 188 | complement activation, alternative pathway (GO:0006957) | 2.12027885 |
| 189 | histone H2A monoubiquitination (GO:0035518) | 2.11347958 |
| 190 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.11319577 |
| 191 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.10940518 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.93322933 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.03726873 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.80796245 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.76569231 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.48057446 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.10642200 |
| 7 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.02339136 |
| 8 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.90580114 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.83038572 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.81083736 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.67118954 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.64272806 |
| 13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.43275946 |
| 14 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 2.41254626 |
| 15 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.21052194 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.19615797 |
| 17 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.13900744 |
| 18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.11967169 |
| 19 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.08783745 |
| 20 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.05160308 |
| 21 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.01493552 |
| 22 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.01493552 |
| 23 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.01493552 |
| 24 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.98739777 |
| 25 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.95748285 |
| 26 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.95600556 |
| 27 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.95396850 |
| 28 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.93690652 |
| 29 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.91118882 |
| 30 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.89364233 |
| 31 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.88472732 |
| 32 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.86328897 |
| 33 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.85512760 |
| 34 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.84705593 |
| 35 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.82161730 |
| 36 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.81288176 |
| 37 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.81240812 |
| 38 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.80476160 |
| 39 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.79901847 |
| 40 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.79323643 |
| 41 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.77889724 |
| 42 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.76827935 |
| 43 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.75215312 |
| 44 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.73449831 |
| 45 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.70167314 |
| 46 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.68856959 |
| 47 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.68506977 |
| 48 | KDM2B_26808549_Chip-Seq_K562_Human | 1.67735106 |
| 49 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.66706618 |
| 50 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.57820005 |
| 51 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.57324107 |
| 52 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.57173839 |
| 53 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.57056610 |
| 54 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.56896320 |
| 55 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.55181622 |
| 56 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.55019434 |
| 57 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.54857423 |
| 58 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.54458288 |
| 59 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.54098102 |
| 60 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.52595491 |
| 61 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.51652486 |
| 62 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.50856822 |
| 63 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.50382206 |
| 64 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.49594174 |
| 65 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.48120159 |
| 66 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.47883711 |
| 67 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.47157529 |
| 68 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.46608164 |
| 69 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.46380915 |
| 70 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.46219378 |
| 71 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.44587598 |
| 72 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.43064907 |
| 73 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.41771479 |
| 74 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.41633853 |
| 75 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.40146927 |
| 76 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.40146927 |
| 77 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.39914705 |
| 78 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.37590282 |
| 79 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.37566447 |
| 80 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.37079725 |
| 81 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.36000218 |
| 82 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.34286928 |
| 83 | P68_20966046_ChIP-Seq_HELA_Human | 1.33225103 |
| 84 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.31793753 |
| 85 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31520677 |
| 86 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.30985478 |
| 87 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.30938630 |
| 88 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.29396775 |
| 89 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.28830752 |
| 90 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.26854855 |
| 91 | * POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.25751522 |
| 92 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.25559447 |
| 93 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.24980586 |
| 94 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.24129267 |
| 95 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.23636954 |
| 96 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.23054810 |
| 97 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.23052967 |
| 98 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.22411022 |
| 99 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.21831610 |
| 100 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.20954269 |
| 101 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.20393384 |
| 102 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.20353977 |
| 103 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.19670730 |
| 104 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.18766111 |
| 105 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.18711869 |
| 106 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.18628940 |
| 107 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.18211767 |
| 108 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.18211631 |
| 109 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.18158870 |
| 110 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18018882 |
| 111 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.17523738 |
| 112 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.17266871 |
| 113 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.16649027 |
| 114 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.15246881 |
| 115 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.15047136 |
| 116 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.14460117 |
| 117 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.13737904 |
| 118 | MYC_22102868_ChIP-Seq_BL_Human | 1.12913911 |
| 119 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.12499967 |
| 120 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.11303846 |
| 121 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.11169737 |
| 122 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.11009392 |
| 123 | MAF_26560356_Chip-Seq_TH1_Human | 1.10000042 |
| 124 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.09974552 |
| 125 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.09788697 |
| 126 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.09765809 |
| 127 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09605784 |
| 128 | * TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.09292130 |
| 129 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.08564215 |
| 130 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.08453578 |
| 131 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.07769126 |
| 132 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.07686749 |
| 133 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.07686749 |
| 134 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.06321970 |
| 135 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.05969895 |
| 136 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.05246882 |
| 137 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.05221326 |
| 138 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04678994 |
| 139 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.04423437 |
| 140 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03596113 |
| 141 | * PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.02985922 |
| 142 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.02864844 |
| 143 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.01964403 |
| 144 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.00750439 |
| 145 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.00404967 |
| 146 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.00320831 |
| 147 | MYB_26560356_Chip-Seq_TH1_Human | 1.00314089 |
| 148 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.00281147 |
| 149 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.98434287 |
| 150 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.97389018 |
| 151 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.96166672 |
| 152 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.94571486 |
| 153 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.92966836 |
| 154 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.92896031 |
| 155 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.92679920 |
| 156 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.92432313 |
| 157 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.92328722 |
| 158 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92231995 |
| 159 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.91548527 |
| 160 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.91348263 |
| 161 | UTX_26944678_Chip-Seq_JUKART_Human | 0.90261806 |
| 162 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.88535128 |
| 163 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.87743283 |
| 164 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.87359715 |
| 165 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87101633 |
| 166 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.86438375 |
| 167 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.86253802 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000751_myopathy | 4.70265713 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.88737297 |
| 3 | MP0004233_abnormal_muscle_weight | 3.47383115 |
| 4 | MP0004145_abnormal_muscle_electrophysio | 3.22322401 |
| 5 | MP0002877_abnormal_melanocyte_morpholog | 2.96315028 |
| 6 | MP0000747_muscle_weakness | 2.95342095 |
| 7 | MP0005360_urolithiasis | 2.90055606 |
| 8 | MP0000759_abnormal_skeletal_muscle | 2.72578196 |
| 9 | MP0002106_abnormal_muscle_physiology | 2.49975356 |
| 10 | MP0002269_muscular_atrophy | 2.48694588 |
| 11 | MP0005365_abnormal_bile_salt | 2.41466362 |
| 12 | MP0005085_abnormal_gallbladder_physiolo | 2.23555384 |
| 13 | MP0003252_abnormal_bile_duct | 2.12724142 |
| 14 | MP0005369_muscle_phenotype | 2.10948374 |
| 15 | MP0005408_hypopigmentation | 2.07148956 |
| 16 | MP0002009_preneoplasia | 2.05913011 |
| 17 | MP0003195_calcinosis | 1.90563746 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 1.84943808 |
| 19 | MP0005623_abnormal_meninges_morphology | 1.75251887 |
| 20 | MP0003300_gastrointestinal_ulcer | 1.72023288 |
| 21 | MP0009840_abnormal_foam_cell | 1.71847185 |
| 22 | MP0000678_abnormal_parathyroid_gland | 1.69829782 |
| 23 | MP0008260_abnormal_autophagy | 1.66353194 |
| 24 | MP0004185_abnormal_adipocyte_glucose | 1.61573041 |
| 25 | MP0005409_darkened_coat_color | 1.61492034 |
| 26 | MP0008438_abnormal_cutaneous_collagen | 1.59924229 |
| 27 | MP0003806_abnormal_nucleotide_metabolis | 1.58820306 |
| 28 | MP0005620_abnormal_muscle_contractility | 1.58813206 |
| 29 | MP0005666_abnormal_adipose_tissue | 1.55246570 |
| 30 | MP0008875_abnormal_xenobiotic_pharmacok | 1.53555220 |
| 31 | MP0004270_analgesia | 1.52469974 |
| 32 | MP0004043_abnormal_pH_regulation | 1.47829900 |
| 33 | MP0002108_abnormal_muscle_morphology | 1.47511902 |
| 34 | MP0001666_abnormal_nutrient_absorption | 1.47485067 |
| 35 | MP0002332_abnormal_exercise_endurance | 1.47367916 |
| 36 | MP0002249_abnormal_larynx_morphology | 1.47142006 |
| 37 | MP0000013_abnormal_adipose_tissue | 1.45865480 |
| 38 | MP0003950_abnormal_plasma_membrane | 1.45190352 |
| 39 | MP0005220_abnormal_exocrine_pancreas | 1.44019843 |
| 40 | MP0001730_embryonic_growth_arrest | 1.39850461 |
| 41 | MP0002972_abnormal_cardiac_muscle | 1.38897496 |
| 42 | MP0005076_abnormal_cell_differentiation | 1.33267709 |
| 43 | MP0003136_yellow_coat_color | 1.30601817 |
| 44 | MP0006054_spinal_hemorrhage | 1.28782969 |
| 45 | MP0005257_abnormal_intraocular_pressure | 1.27115091 |
| 46 | MP0010030_abnormal_orbit_morphology | 1.26741922 |
| 47 | MP0003646_muscle_fatigue | 1.25894186 |
| 48 | MP0006138_congestive_heart_failure | 1.23746770 |
| 49 | MP0005083_abnormal_biliary_tract | 1.22562315 |
| 50 | MP0002138_abnormal_hepatobiliary_system | 1.22334163 |
| 51 | MP0009053_abnormal_anal_canal | 1.22111337 |
| 52 | MP0003123_paternal_imprinting | 1.20619477 |
| 53 | MP0005332_abnormal_amino_acid | 1.19044356 |
| 54 | MP0004858_abnormal_nervous_system | 1.18922026 |
| 55 | MP0009780_abnormal_chondrocyte_physiolo | 1.18734692 |
| 56 | MP0002166_altered_tumor_susceptibility | 1.18194579 |
| 57 | MP0009384_cardiac_valve_regurgitation | 1.17168451 |
| 58 | MP0000609_abnormal_liver_physiology | 1.16463793 |
| 59 | MP0004381_abnormal_hair_follicle | 1.16388107 |
| 60 | MP0001661_extended_life_span | 1.15710218 |
| 61 | MP0003453_abnormal_keratinocyte_physiol | 1.15247445 |
| 62 | MP0003011_delayed_dark_adaptation | 1.15077305 |
| 63 | MP0009643_abnormal_urine_homeostasis | 1.13933764 |
| 64 | MP0005375_adipose_tissue_phenotype | 1.13892184 |
| 65 | MP0001346_abnormal_lacrimal_gland | 1.13556886 |
| 66 | MP0001849_ear_inflammation | 1.11165662 |
| 67 | MP0004510_myositis | 1.10928432 |
| 68 | MP0005248_abnormal_Harderian_gland | 1.10297129 |
| 69 | MP0010234_abnormal_vibrissa_follicle | 1.10250270 |
| 70 | MP0004859_abnormal_synaptic_plasticity | 1.09358841 |
| 71 | MP0003566_abnormal_cell_adhesion | 1.06558291 |
| 72 | MP0006036_abnormal_mitochondrial_physio | 1.05681586 |
| 73 | MP0002127_abnormal_cardiovascular_syste | 1.05569279 |
| 74 | MP0010329_abnormal_lipoprotein_level | 1.04966876 |
| 75 | MP0005670_abnormal_white_adipose | 1.01528320 |
| 76 | MP0000566_synostosis | 1.00877514 |
| 77 | MP0000749_muscle_degeneration | 1.00339881 |
| 78 | MP0002822_catalepsy | 0.99990123 |
| 79 | MP0003879_abnormal_hair_cell | 0.99597949 |
| 80 | MP0001944_abnormal_pancreas_morphology | 0.98255717 |
| 81 | MP0001299_abnormal_eye_distance/ | 0.97894253 |
| 82 | MP0003567_abnormal_fetal_cardiomyocyte | 0.96186327 |
| 83 | MP0010368_abnormal_lymphatic_system | 0.94410421 |
| 84 | MP0000762_abnormal_tongue_morphology | 0.94024499 |
| 85 | MP0005380_embryogenesis_phenotype | 0.93982871 |
| 86 | MP0001672_abnormal_embryogenesis/_devel | 0.93982871 |
| 87 | MP0000613_abnormal_salivary_gland | 0.93651282 |
| 88 | MP0005385_cardiovascular_system_phenoty | 0.93444863 |
| 89 | MP0001544_abnormal_cardiovascular_syste | 0.93444863 |
| 90 | MP0002837_dystrophic_cardiac_calcinosis | 0.92442817 |
| 91 | MP0005451_abnormal_body_composition | 0.91231404 |
| 92 | MP0003077_abnormal_cell_cycle | 0.90853877 |
| 93 | MP0004272_abnormal_basement_membrane | 0.90718374 |
| 94 | MP0010352_gastrointestinal_tract_polyps | 0.90549059 |
| 95 | MP0003937_abnormal_limbs/digits/tail_de | 0.89102064 |
| 96 | MP0010630_abnormal_cardiac_muscle | 0.88973182 |
| 97 | MP0003984_embryonic_growth_retardation | 0.88799334 |
| 98 | MP0005023_abnormal_wound_healing | 0.88522534 |
| 99 | MP0003091_abnormal_cell_migration | 0.87695180 |
| 100 | MP0000350_abnormal_cell_proliferation | 0.86884747 |
| 101 | MP0004087_abnormal_muscle_fiber | 0.86290170 |
| 102 | MP0000733_abnormal_muscle_development | 0.85729986 |
| 103 | MP0002118_abnormal_lipid_homeostasis | 0.83679234 |
| 104 | MP0003724_increased_susceptibility_to | 0.83560464 |
| 105 | MP0004484_altered_response_of | 0.82834855 |
| 106 | MP0002088_abnormal_embryonic_growth/wei | 0.80869836 |
| 107 | MP0000750_abnormal_muscle_regeneration | 0.80578991 |
| 108 | MP0003186_abnormal_redox_activity | 0.80072748 |
| 109 | MP0000428_abnormal_craniofacial_morphol | 0.79679454 |
| 110 | MP0000534_abnormal_ureter_morphology | 0.79578096 |
| 111 | MP0004264_abnormal_extraembryonic_tissu | 0.78046310 |
| 112 | MP0000266_abnormal_heart_morphology | 0.77353591 |
| 113 | MP0005647_abnormal_sex_gland | 0.77233291 |
| 114 | MP0004215_abnormal_myocardial_fiber | 0.77184206 |
| 115 | MP0002693_abnormal_pancreas_physiology | 0.76864050 |
| 116 | MP0003868_abnormal_feces_composition | 0.76657418 |
| 117 | MP0003111_abnormal_nucleus_morphology | 0.76641788 |
| 118 | MP0002928_abnormal_bile_duct | 0.76225548 |
| 119 | MP0004084_abnormal_cardiac_muscle | 0.76052069 |
| 120 | MP0002080_prenatal_lethality | 0.76021374 |
| 121 | MP0005423_abnormal_somatic_nervous | 0.75764617 |
| 122 | MP0000003_abnormal_adipose_tissue | 0.75565047 |
| 123 | MP0000598_abnormal_liver_morphology | 0.75472256 |
| 124 | MP0003221_abnormal_cardiomyocyte_apopto | 0.75092832 |
| 125 | MP0005319_abnormal_enzyme/_coenzyme | 0.74378954 |
| 126 | MP0002114_abnormal_axial_skeleton | 0.74303165 |
| 127 | MP0002084_abnormal_developmental_patter | 0.74134645 |
| 128 | MP0000767_abnormal_smooth_muscle | 0.73717277 |
| 129 | MP0002078_abnormal_glucose_homeostasis | 0.73036412 |
| 130 | MP0005330_cardiomyopathy | 0.72988811 |
| 131 | MP0002006_tumorigenesis | 0.72955369 |
| 132 | MP0001915_intracranial_hemorrhage | 0.72625230 |
| 133 | MP0004036_abnormal_muscle_relaxation | 0.71346122 |
| 134 | MP0003329_amyloid_beta_deposits | 0.71167267 |
| 135 | MP0002168_other_aberrant_phenotype | 0.70969072 |
| 136 | MP0002085_abnormal_embryonic_tissue | 0.69207234 |
| 137 | MP0000537_abnormal_urethra_morphology | 0.67659189 |
| 138 | MP0002896_abnormal_bone_mineralization | 0.67640137 |
| 139 | MP0003279_aneurysm | 0.67521227 |
| 140 | MP0008932_abnormal_embryonic_tissue | 0.67306739 |
| 141 | MP0003828_pulmonary_edema | 0.67036195 |
| 142 | MP0002210_abnormal_sex_determination | 0.66701969 |
| 143 | MP0005395_other_phenotype | 0.66685562 |
| 144 | MP0005275_abnormal_skin_tensile | 0.66685507 |
| 145 | MP0003045_fibrosis | 0.66316163 |
| 146 | MP0003385_abnormal_body_wall | 0.66047160 |
| 147 | MP0000467_abnormal_esophagus_morphology | 0.65964734 |
| 148 | MP0002971_abnormal_brown_adipose | 0.64800830 |
| 149 | MP0004130_abnormal_muscle_cell | 0.64538932 |
| 150 | MP0003942_abnormal_urinary_system | 0.64499812 |
| 151 | MP0009703_decreased_birth_body | 0.64443327 |
| 152 | MP0004019_abnormal_vitamin_homeostasis | 0.64430469 |
| 153 | MP0002089_abnormal_postnatal_growth/wei | 0.64280002 |
| 154 | MP0000377_abnormal_hair_follicle | 0.63925545 |
| 155 | MP0000371_diluted_coat_color | 0.63848698 |
| 156 | MP0002060_abnormal_skin_morphology | 0.63296807 |
| 157 | MP0009672_abnormal_birth_weight | 0.63084813 |
| 158 | MP0001697_abnormal_embryo_size | 0.62469423 |
| 159 | MP0001879_abnormal_lymphatic_vessel | 0.62324170 |
| 160 | MP0008569_lethality_at_weaning | 0.62109241 |
| 161 | MP0003693_abnormal_embryo_hatching | 0.61845292 |
| 162 | MP0006072_abnormal_retinal_apoptosis | 0.61241915 |
| 163 | MP0004197_abnormal_fetal_growth/weight/ | 0.60828840 |
| 164 | MP0006035_abnormal_mitochondrial_morpho | 0.60502538 |
| 165 | MP0005621_abnormal_cell_physiology | 0.60402818 |
| 166 | MP0005187_abnormal_penis_morphology | 0.59526167 |
| 167 | MP0002128_abnormal_blood_circulation | 0.59309704 |
| 168 | MP0001919_abnormal_reproductive_system | 0.58494761 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 6.51104335 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.45648548 |
| 3 | Myopathic facies (HP:0002058) | 4.34191248 |
| 4 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.17246611 |
| 5 | Hypoglycemic coma (HP:0001325) | 4.05568488 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 3.97328985 |
| 7 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.76144532 |
| 8 | Increased variability in muscle fiber diameter (HP:0003557) | 3.58455691 |
| 9 | Distal lower limb muscle weakness (HP:0009053) | 3.54617450 |
| 10 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.49259862 |
| 11 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.47315356 |
| 12 | Rimmed vacuoles (HP:0003805) | 3.35630433 |
| 13 | Bundle branch block (HP:0011710) | 3.29525895 |
| 14 | Abnormality of the calf musculature (HP:0001430) | 3.27528478 |
| 15 | Abnormal gallbladder physiology (HP:0012438) | 3.23696784 |
| 16 | Cholecystitis (HP:0001082) | 3.23696784 |
| 17 | Difficulty running (HP:0009046) | 3.11263897 |
| 18 | Neck muscle weakness (HP:0000467) | 3.07268051 |
| 19 | Distal arthrogryposis (HP:0005684) | 3.03408519 |
| 20 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.02332019 |
| 21 | Hypoglycemic seizures (HP:0002173) | 2.98892250 |
| 22 | Calcaneovalgus deformity (HP:0001848) | 2.94535131 |
| 23 | Xanthomatosis (HP:0000991) | 2.93457347 |
| 24 | Hyperglycinuria (HP:0003108) | 2.93292102 |
| 25 | Exercise-induced muscle cramps (HP:0003710) | 2.92681765 |
| 26 | Muscle stiffness (HP:0003552) | 2.91684494 |
| 27 | Hyperglycemia (HP:0003074) | 2.90237413 |
| 28 | Deep venous thrombosis (HP:0002625) | 2.85387146 |
| 29 | Ulnar deviation of the wrist (HP:0003049) | 2.79163475 |
| 30 | Sudden death (HP:0001699) | 2.79101996 |
| 31 | Late onset (HP:0003584) | 2.73771214 |
| 32 | Distal lower limb amyotrophy (HP:0008944) | 2.72069105 |
| 33 | Myocardial infarction (HP:0001658) | 2.71741510 |
| 34 | Ragged-red muscle fibers (HP:0003200) | 2.70222617 |
| 35 | Ketoacidosis (HP:0001993) | 2.69083778 |
| 36 | Ketosis (HP:0001946) | 2.68728639 |
| 37 | Abnormality of the common coagulation pathway (HP:0010990) | 2.65230958 |
| 38 | Shoulder girdle muscle weakness (HP:0003547) | 2.63556111 |
| 39 | Dysmetric saccades (HP:0000641) | 2.61639371 |
| 40 | Progressive muscle weakness (HP:0003323) | 2.58271605 |
| 41 | Hyporeflexia of lower limbs (HP:0002600) | 2.54830874 |
| 42 | Myoglobinuria (HP:0002913) | 2.54386901 |
| 43 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.53260035 |
| 44 | Deformed tarsal bones (HP:0008119) | 2.51881549 |
| 45 | Pigmentary retinal degeneration (HP:0001146) | 2.50753229 |
| 46 | Fat malabsorption (HP:0002630) | 2.50273450 |
| 47 | Increased connective tissue (HP:0009025) | 2.46601445 |
| 48 | Limb-girdle muscle atrophy (HP:0003797) | 2.45524703 |
| 49 | Scapular winging (HP:0003691) | 2.43284951 |
| 50 | Hyperglycinemia (HP:0002154) | 2.42215792 |
| 51 | Spinal rigidity (HP:0003306) | 2.42112118 |
| 52 | Chorioretinal atrophy (HP:0000533) | 2.41428023 |
| 53 | Abnormality of glycine metabolism (HP:0010895) | 2.41265733 |
| 54 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.41265733 |
| 55 | Abnormality of the calcaneus (HP:0008364) | 2.40914894 |
| 56 | Subaortic stenosis (HP:0001682) | 2.39349445 |
| 57 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.39349445 |
| 58 | Joint hemorrhage (HP:0005261) | 2.39046055 |
| 59 | Abnormality of the foot musculature (HP:0001436) | 2.36433978 |
| 60 | Difficulty climbing stairs (HP:0003551) | 2.36141734 |
| 61 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.34777375 |
| 62 | EMG: neuropathic changes (HP:0003445) | 2.34646286 |
| 63 | Foot dorsiflexor weakness (HP:0009027) | 2.29920939 |
| 64 | Right ventricular cardiomyopathy (HP:0011663) | 2.28581773 |
| 65 | Hypoalphalipoproteinemia (HP:0003233) | 2.26533572 |
| 66 | Achilles tendon contracture (HP:0001771) | 2.25863622 |
| 67 | Muscle fiber splitting (HP:0003555) | 2.24320906 |
| 68 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.23288768 |
| 69 | Prolonged partial thromboplastin time (HP:0003645) | 2.23272519 |
| 70 | Hepatocellular carcinoma (HP:0001402) | 2.22843559 |
| 71 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.21005758 |
| 72 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.21005758 |
| 73 | Bulbar palsy (HP:0001283) | 2.19964378 |
| 74 | Abnormality of chloride homeostasis (HP:0011422) | 2.19221016 |
| 75 | Obstructive sleep apnea (HP:0002870) | 2.18758943 |
| 76 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.18030760 |
| 77 | Complement deficiency (HP:0004431) | 2.16143296 |
| 78 | Frequent falls (HP:0002359) | 2.16119724 |
| 79 | Abnormality of the intrinsic pathway (HP:0010989) | 2.16033144 |
| 80 | Fetal akinesia sequence (HP:0001989) | 2.15731953 |
| 81 | Lower limb amyotrophy (HP:0007210) | 2.13863761 |
| 82 | Distal upper limb amyotrophy (HP:0007149) | 2.13704645 |
| 83 | Upper limb amyotrophy (HP:0009129) | 2.13704645 |
| 84 | Limb-girdle muscle weakness (HP:0003325) | 2.11877139 |
| 85 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.10749974 |
| 86 | Rhabdomyolysis (HP:0003201) | 2.10514645 |
| 87 | Esophageal varix (HP:0002040) | 2.10394674 |
| 88 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.07065271 |
| 89 | Hypercortisolism (HP:0001578) | 2.05420026 |
| 90 | Generalized aminoaciduria (HP:0002909) | 2.04545141 |
| 91 | Exocrine pancreatic insufficiency (HP:0001738) | 2.04194579 |
| 92 | Insulin resistance (HP:0000855) | 2.02444508 |
| 93 | Abnormality of the fingertips (HP:0001211) | 2.01452731 |
| 94 | Hypolipoproteinemia (HP:0010981) | 2.00392934 |
| 95 | Facial shape deformation (HP:0011334) | 1.99643819 |
| 96 | Potter facies (HP:0002009) | 1.99643819 |
| 97 | Abnormality of the Achilles tendon (HP:0005109) | 1.99622651 |
| 98 | Abnormal atrioventricular conduction (HP:0005150) | 1.99417891 |
| 99 | Abnormality of purine metabolism (HP:0004352) | 1.99339791 |
| 100 | Symptomatic seizures (HP:0011145) | 1.99249945 |
| 101 | Cholelithiasis (HP:0001081) | 1.98377050 |
| 102 | Protrusio acetabuli (HP:0003179) | 1.98377005 |
| 103 | Epidermoid cyst (HP:0200040) | 1.98348713 |
| 104 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.96330773 |
| 105 | Heart block (HP:0012722) | 1.93629463 |
| 106 | Rectal prolapse (HP:0002035) | 1.91860183 |
| 107 | Hand muscle atrophy (HP:0009130) | 1.91518380 |
| 108 | Pelvic girdle muscle weakness (HP:0003749) | 1.91093237 |
| 109 | Hyperammonemia (HP:0001987) | 1.89514984 |
| 110 | Abnormality of glycolysis (HP:0004366) | 1.89222061 |
| 111 | Metatarsus adductus (HP:0001840) | 1.88168805 |
| 112 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.87845402 |
| 113 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.87845402 |
| 114 | Conjugated hyperbilirubinemia (HP:0002908) | 1.86897138 |
| 115 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.85723451 |
| 116 | Hyperacusis (HP:0010780) | 1.85638566 |
| 117 | Hypobetalipoproteinemia (HP:0003563) | 1.83151150 |
| 118 | Abnormality of nucleobase metabolism (HP:0010932) | 1.82037963 |
| 119 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.81735476 |
| 120 | Breech presentation (HP:0001623) | 1.81680887 |
| 121 | Areflexia of lower limbs (HP:0002522) | 1.81521667 |
| 122 | Hyperactive renin-angiotensin system (HP:0000841) | 1.81016981 |
| 123 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.80570319 |
| 124 | Steatorrhea (HP:0002570) | 1.80506770 |
| 125 | Generalized muscle weakness (HP:0003324) | 1.79110429 |
| 126 | Premature rupture of membranes (HP:0001788) | 1.78720653 |
| 127 | Ventricular tachycardia (HP:0004756) | 1.78668264 |
| 128 | Abnormality of complement system (HP:0005339) | 1.78244354 |
| 129 | Vertebral arch anomaly (HP:0008438) | 1.76212441 |
| 130 | Type 1 muscle fiber predominance (HP:0003803) | 1.75888804 |
| 131 | Abnormality of the lower motor neuron (HP:0002366) | 1.75780957 |
| 132 | Calf muscle hypertrophy (HP:0008981) | 1.75060870 |
| 133 | Abnormal hemoglobin (HP:0011902) | 1.74962585 |
| 134 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.74862542 |
| 135 | Gowers sign (HP:0003391) | 1.74567571 |
| 136 | Pseudobulbar signs (HP:0002200) | 1.73806586 |
| 137 | Absent phalangeal crease (HP:0006109) | 1.73609599 |
| 138 | Stridor (HP:0010307) | 1.73271148 |
| 139 | Gout (HP:0001997) | 1.71280420 |
| 140 | Malignant hyperthermia (HP:0002047) | 1.70697545 |
| 141 | Abnormal gallbladder morphology (HP:0012437) | 1.70341564 |
| 142 | Diaphragmatic weakness (HP:0009113) | 1.69376810 |
| 143 | Lip pit (HP:0100267) | 1.68710456 |
| 144 | Back pain (HP:0003418) | 1.68425695 |
| 145 | Myotonia (HP:0002486) | 1.67931743 |
| 146 | Ulnar bowing (HP:0003031) | 1.67909251 |
| 147 | Round ear (HP:0100830) | 1.67388749 |
| 148 | Progressive external ophthalmoplegia (HP:0000590) | 1.66669679 |
| 149 | Slender build (HP:0001533) | 1.66542302 |
| 150 | Reticulocytosis (HP:0001923) | 1.66161669 |
| 151 | Cone-rod dystrophy (HP:0000548) | 1.62734549 |
| 152 | Deep palmar crease (HP:0006191) | 1.61875199 |
| 153 | Waddling gait (HP:0002515) | 1.60844822 |
| 154 | Hammertoe (HP:0001765) | 1.60748378 |
| 155 | Hyperkalemia (HP:0002153) | 1.59963864 |
| 156 | Abnormal sex determination (HP:0012244) | 1.59857856 |
| 157 | Sex reversal (HP:0012245) | 1.59857856 |
| 158 | Atelectasis (HP:0100750) | 1.59437753 |
| 159 | Subacute progressive viral hepatitis (HP:0006572) | 1.59001427 |
| 160 | Proximal amyotrophy (HP:0007126) | 1.58518556 |
| 161 | Dilated cardiomyopathy (HP:0001644) | 1.58391030 |
| 162 | Prenatal maternal abnormality (HP:0002686) | 1.58043910 |
| 163 | Lipoatrophy (HP:0100578) | 1.57553615 |
| 164 | EMG: myopathic abnormalities (HP:0003458) | 1.57409409 |
| 165 | Abnormality of the gallbladder (HP:0005264) | 1.56548294 |
| 166 | Exercise-induced myalgia (HP:0003738) | 1.56302766 |
| 167 | Asymmetric septal hypertrophy (HP:0001670) | 1.55971818 |
| 168 | Pancreatitis (HP:0001733) | 1.55850471 |
| 169 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.55472068 |
| 170 | Hyperbilirubinemia (HP:0002904) | 1.54968793 |
| 171 | Aneurysm (HP:0002617) | 1.54348892 |
| 172 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.53529668 |
| 173 | Mitral stenosis (HP:0001718) | 1.53086587 |
| 174 | Abnormality of methionine metabolism (HP:0010901) | 1.50687862 |
| 175 | Muscle fiber inclusion bodies (HP:0100299) | 1.50230475 |
| 176 | Lymphangioma (HP:0100764) | 1.50003843 |
| 177 | Skin nodule (HP:0200036) | 1.49756699 |
| 178 | Hydroxyprolinuria (HP:0003080) | 1.48277493 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 2.79642075 |
| 2 | LATS1 | 2.64843536 |
| 3 | ARAF | 2.56435932 |
| 4 | TRIB3 | 2.50623677 |
| 5 | PHKG1 | 2.48194510 |
| 6 | PHKG2 | 2.48194510 |
| 7 | ICK | 2.40044102 |
| 8 | MKNK2 | 2.38447174 |
| 9 | SMG1 | 2.37525613 |
| 10 | PKN2 | 2.34423416 |
| 11 | INSRR | 2.31291983 |
| 12 | MAP3K9 | 2.13106351 |
| 13 | BCKDK | 2.11667569 |
| 14 | FRK | 2.09734388 |
| 15 | SIK1 | 2.01001725 |
| 16 | NEK9 | 2.00635187 |
| 17 | TAOK3 | 1.99560216 |
| 18 | KSR2 | 1.92160986 |
| 19 | FLT3 | 1.90768480 |
| 20 | CDK12 | 1.77359285 |
| 21 | ERN1 | 1.72138625 |
| 22 | MOS | 1.70983365 |
| 23 | EPHB1 | 1.70090192 |
| 24 | BRAF | 1.69107016 |
| 25 | MAPK15 | 1.66650950 |
| 26 | TLK1 | 1.54248629 |
| 27 | MAP3K13 | 1.54094956 |
| 28 | TTN | 1.53473333 |
| 29 | IRAK3 | 1.51313609 |
| 30 | STK10 | 1.45619819 |
| 31 | TAOK2 | 1.44189780 |
| 32 | FGFR4 | 1.42890627 |
| 33 | PTK6 | 1.42218896 |
| 34 | LATS2 | 1.41346863 |
| 35 | STK38L | 1.38895161 |
| 36 | STK3 | 1.35792451 |
| 37 | KSR1 | 1.33486955 |
| 38 | MAP3K14 | 1.32822027 |
| 39 | NLK | 1.29039817 |
| 40 | WNK4 | 1.28780074 |
| 41 | FGFR3 | 1.27799352 |
| 42 | PRKD2 | 1.27411416 |
| 43 | MET | 1.25837156 |
| 44 | MAP3K10 | 1.24709413 |
| 45 | ERBB4 | 1.16262038 |
| 46 | RIPK1 | 1.15486813 |
| 47 | EEF2K | 1.15382887 |
| 48 | EPHA3 | 1.13967166 |
| 49 | MAP2K2 | 1.13251232 |
| 50 | PRKD3 | 1.12820447 |
| 51 | MKNK1 | 1.12390940 |
| 52 | HIPK2 | 1.10901952 |
| 53 | PBK | 1.08224154 |
| 54 | OBSCN | 1.06131163 |
| 55 | CDK19 | 1.03588921 |
| 56 | IRAK1 | 1.03230678 |
| 57 | PIK3CG | 1.03149641 |
| 58 | JAK3 | 1.02524998 |
| 59 | AKT2 | 1.02365542 |
| 60 | CDK6 | 1.01932068 |
| 61 | TESK1 | 1.01506381 |
| 62 | MAP3K3 | 0.98451322 |
| 63 | PDGFRA | 0.94455279 |
| 64 | SCYL2 | 0.93877280 |
| 65 | PASK | 0.93813927 |
| 66 | DMPK | 0.92208838 |
| 67 | RAF1 | 0.91803907 |
| 68 | STK39 | 0.91758502 |
| 69 | MARK2 | 0.90995847 |
| 70 | TRPM7 | 0.90124863 |
| 71 | MAP3K7 | 0.90020445 |
| 72 | CAMK1G | 0.90002253 |
| 73 | MAPK12 | 0.89941211 |
| 74 | CHUK | 0.87443367 |
| 75 | MST4 | 0.87290245 |
| 76 | TSSK6 | 0.84533208 |
| 77 | MAP2K3 | 0.84464609 |
| 78 | PAK6 | 0.84054152 |
| 79 | NEK1 | 0.83787115 |
| 80 | BRD4 | 0.81466588 |
| 81 | FER | 0.81124472 |
| 82 | PIM1 | 0.80276191 |
| 83 | STK4 | 0.80139222 |
| 84 | GSK3A | 0.78895715 |
| 85 | RPS6KA4 | 0.78350560 |
| 86 | STK38 | 0.77485304 |
| 87 | PRKAA2 | 0.76642315 |
| 88 | PNCK | 0.75208769 |
| 89 | MTOR | 0.73306585 |
| 90 | EPHA2 | 0.73043003 |
| 91 | LRRK2 | 0.71465750 |
| 92 | MELK | 0.70567341 |
| 93 | BMX | 0.70560955 |
| 94 | NUAK1 | 0.69660305 |
| 95 | CDK9 | 0.69329311 |
| 96 | PRKD1 | 0.68727399 |
| 97 | CDK4 | 0.68008753 |
| 98 | CSK | 0.67939923 |
| 99 | PDPK1 | 0.67494964 |
| 100 | TAOK1 | 0.67474806 |
| 101 | MAPK11 | 0.65644479 |
| 102 | JAK2 | 0.65381070 |
| 103 | DYRK1B | 0.65353574 |
| 104 | AKT3 | 0.64288247 |
| 105 | MARK1 | 0.64210307 |
| 106 | FGFR2 | 0.63151419 |
| 107 | NEK6 | 0.63007788 |
| 108 | IRAK2 | 0.62629060 |
| 109 | PAK2 | 0.62390926 |
| 110 | MAP2K4 | 0.60511632 |
| 111 | AURKA | 0.60221047 |
| 112 | TYK2 | 0.60195702 |
| 113 | STK24 | 0.59425560 |
| 114 | CDK7 | 0.59225893 |
| 115 | CAMK2G | 0.58146533 |
| 116 | JAK1 | 0.57900069 |
| 117 | RET | 0.57477500 |
| 118 | PTK2 | 0.56292570 |
| 119 | PIM2 | 0.55616996 |
| 120 | SGK2 | 0.54937414 |
| 121 | SGK3 | 0.54757366 |
| 122 | ZAP70 | 0.52167588 |
| 123 | MAPK10 | 0.51671124 |
| 124 | MAP3K2 | 0.51214995 |
| 125 | MUSK | 0.50583008 |
| 126 | MAP3K8 | 0.50460382 |
| 127 | PDGFRB | 0.49594555 |
| 128 | MAP3K11 | 0.49441765 |
| 129 | MST1R | 0.47493418 |
| 130 | PRKAA1 | 0.47486916 |
| 131 | CAMK4 | 0.47453267 |
| 132 | TGFBR2 | 0.46623995 |
| 133 | CHEK1 | 0.45882672 |
| 134 | IKBKE | 0.45600214 |
| 135 | SRPK1 | 0.45447998 |
| 136 | RPS6KB1 | 0.45389672 |
| 137 | TTK | 0.45329092 |
| 138 | ILK | 0.45322672 |
| 139 | MAP3K1 | 0.45238087 |
| 140 | SIK2 | 0.45190315 |
| 141 | CDK11A | 0.44954154 |
| 142 | MAPKAPK2 | 0.44927775 |
| 143 | WNK1 | 0.43953272 |
| 144 | RPS6KB2 | 0.43455933 |
| 145 | WNK3 | 0.43251128 |
| 146 | UHMK1 | 0.43134483 |
| 147 | NTRK1 | 0.42392820 |
| 148 | ITK | 0.42079205 |
| 149 | CLK1 | 0.42049696 |
| 150 | IKBKB | 0.41785745 |
| 151 | RPS6KA5 | 0.41347683 |
| 152 | PRKCH | 0.40855589 |
| 153 | PDK1 | 0.40590987 |
| 154 | MAPKAPK3 | 0.38385648 |
| 155 | MAP2K1 | 0.37854702 |
| 156 | ZAK | 0.37848386 |
| 157 | MARK3 | 0.37376331 |
| 158 | LMTK2 | 0.35446072 |
| 159 | CDK15 | 0.34932745 |
| 160 | LIMK1 | 0.34906888 |
| 161 | SIK3 | 0.34521209 |
| 162 | MAP3K5 | 0.33886135 |
| 163 | CDK2 | 0.32809647 |
| 164 | TRIM28 | 0.32365659 |
| 165 | CDK18 | 0.32319560 |
| 166 | CDK14 | 0.31840155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.09416782 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.73805307 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.48036060 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.35152356 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.11847255 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.10458199 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.05152385 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.97957136 |
| 9 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.97460916 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.91794513 |
| 11 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.91063259 |
| 12 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.89988150 |
| 13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.87703599 |
| 14 | Protein export_Homo sapiens_hsa03060 | 1.85813043 |
| 15 | Circadian rhythm_Homo sapiens_hsa04710 | 1.78394543 |
| 16 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.70358525 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.69809878 |
| 18 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.69137094 |
| 19 | Lysine degradation_Homo sapiens_hsa00310 | 1.65337478 |
| 20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.58437418 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.54942290 |
| 22 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.52634200 |
| 23 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.51332736 |
| 24 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.48657184 |
| 25 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.47974560 |
| 26 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.46641958 |
| 27 | Endometrial cancer_Homo sapiens_hsa05213 | 1.46630605 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.46037977 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.43549642 |
| 30 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.43399952 |
| 31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.36278970 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.36229870 |
| 33 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.35705472 |
| 34 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.34648009 |
| 35 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.32418789 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.27440691 |
| 37 | Histidine metabolism_Homo sapiens_hsa00340 | 1.27202372 |
| 38 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.26645872 |
| 39 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.25629620 |
| 40 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.25497846 |
| 41 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.24046711 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.22550601 |
| 43 | Long-term potentiation_Homo sapiens_hsa04720 | 1.21258948 |
| 44 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.21078633 |
| 45 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.19381739 |
| 46 | Glioma_Homo sapiens_hsa05214 | 1.18875693 |
| 47 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.13657335 |
| 48 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.13589112 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.11198383 |
| 50 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.10572441 |
| 51 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.10379772 |
| 52 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.09283690 |
| 53 | Prion diseases_Homo sapiens_hsa05020 | 1.09240762 |
| 54 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.07842807 |
| 55 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.07489563 |
| 56 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.07304914 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 1.06538241 |
| 58 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.06377296 |
| 59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.04405548 |
| 60 | Prostate cancer_Homo sapiens_hsa05215 | 1.03965569 |
| 61 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.03358907 |
| 62 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.02298381 |
| 63 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.01738912 |
| 64 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.99196623 |
| 65 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.98213691 |
| 66 | Insulin resistance_Homo sapiens_hsa04931 | 0.98052405 |
| 67 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.97245046 |
| 68 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.94434425 |
| 69 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.92863746 |
| 70 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.92021808 |
| 71 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.91386094 |
| 72 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91186888 |
| 73 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.90251541 |
| 74 | Colorectal cancer_Homo sapiens_hsa05210 | 0.89855518 |
| 75 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.88345340 |
| 76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.87773187 |
| 77 | Adherens junction_Homo sapiens_hsa04520 | 0.86789251 |
| 78 | Cell cycle_Homo sapiens_hsa04110 | 0.86589825 |
| 79 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.84394394 |
| 80 | Carbon metabolism_Homo sapiens_hsa01200 | 0.84127588 |
| 81 | Gap junction_Homo sapiens_hsa04540 | 0.82866920 |
| 82 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.82827894 |
| 83 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.82399629 |
| 84 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.82385434 |
| 85 | Thyroid cancer_Homo sapiens_hsa05216 | 0.81657246 |
| 86 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.80287439 |
| 87 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.78729257 |
| 88 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.77354717 |
| 89 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.76458604 |
| 90 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.76344958 |
| 91 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75944473 |
| 92 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.75251080 |
| 93 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.75114430 |
| 94 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.74820450 |
| 95 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.74491399 |
| 96 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73141994 |
| 97 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.72221708 |
| 98 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.70224160 |
| 99 | Sulfur relay system_Homo sapiens_hsa04122 | 0.69769364 |
| 100 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.69471137 |
| 101 | Other glycan degradation_Homo sapiens_hsa00511 | 0.69105426 |
| 102 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.69083603 |
| 103 | Bladder cancer_Homo sapiens_hsa05219 | 0.67300407 |
| 104 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66653738 |
| 105 | Melanogenesis_Homo sapiens_hsa04916 | 0.66181221 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64521518 |
| 107 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.62765346 |
| 108 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.62638886 |
| 109 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62215491 |
| 110 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.60706495 |
| 111 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.60687352 |
| 112 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58700092 |
| 113 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.58422644 |
| 114 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.58266169 |
| 115 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.58239382 |
| 116 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.57701789 |
| 117 | Focal adhesion_Homo sapiens_hsa04510 | 0.57417926 |
| 118 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.56684601 |
| 119 | RNA transport_Homo sapiens_hsa03013 | 0.56238414 |
| 120 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.55031507 |
| 121 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55006776 |
| 122 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.54888993 |
| 123 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.54011729 |
| 124 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.53605618 |
| 125 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.53002724 |
| 126 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52116769 |
| 127 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51880282 |
| 128 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.51634808 |
| 129 | Bile secretion_Homo sapiens_hsa04976 | 0.50935907 |
| 130 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.50934960 |
| 131 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.49913446 |
| 132 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.49441893 |
| 133 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.49438523 |
| 134 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.49065117 |
| 135 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.48870273 |
| 136 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.47697249 |
| 137 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.47555659 |
| 138 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.46046198 |
| 139 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45729542 |
| 140 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.44736876 |
| 141 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44515106 |
| 142 | Amoebiasis_Homo sapiens_hsa05146 | 0.43163283 |
| 143 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42405196 |
| 144 | Melanoma_Homo sapiens_hsa05218 | 0.41296700 |
| 145 | Base excision repair_Homo sapiens_hsa03410 | 0.40815503 |
| 146 | Tight junction_Homo sapiens_hsa04530 | 0.40766999 |
| 147 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.40354783 |
| 148 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.40206308 |
| 149 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.39037565 |
| 150 | Endocytosis_Homo sapiens_hsa04144 | 0.38706442 |
| 151 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38688057 |
| 152 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.37397002 |
| 153 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35936354 |
| 154 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.35702190 |
| 155 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.34834924 |
| 156 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.34723998 |
| 157 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.34689444 |
| 158 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.33870415 |
| 159 | Viral myocarditis_Homo sapiens_hsa05416 | 0.33847168 |
| 160 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.33131427 |
| 161 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.32854155 |
| 162 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.32723060 |

